<p>The survival rates of the PP4 or PP6 synthetic peptide-immunized mice after infection with the clinically invasive A1 (A) or A20 GAS strains (B). Groups of 5 to 9 BALB/c mice were immunized with the control peptide (n = 5), synthetic peptide PP4 (n = 5) or synthetic peptide PP6 (n = 9) and inoculated via the air pouch route with 2× 10<sup>8</sup> CFU of the A1 or A20 GAS strains. The survival curves were compared for significance using the log-rank test for the PP6-immunized mice versus the control group (<i>P</i>< 0.01). (C) The area of the skin lesions around the air pouch of the control (n = 5) or PP6-immunized mice (n = 9) at 48 h after A1 or A20 GAS strain infection. *<i>P</i>< 0.05, **<i>P</i>< 0.01, compared with the values determ...
Flow chart depicts the schedule and dose of challenge with live P. aeruginosa and treatment with SPA...
<p><b>A.</b> For therapeutic vaccination, mice (n = 5 per group) were inoculated with ID8-G7 tumor c...
<p>MUC1.Tg mice were given two peptide immunizations before and two after tumor challenges. Three ou...
<p>(A) The survival rates of synthetic peptide SLSpp, PP6, or a combination of two peptides (SLSpp/P...
<p>To assess the longevity of immunity developed following sequential infections, BALB/c mice (n = 2...
<p>BALB/c mice (n = 20/group; female, 4–6 weeks old) were sequentially infected multiple times with ...
<p>Bacterial burden in tissues was significantly lower in animal immunized with Peptide B especially...
<p>(A) Mice were i.n immunized three times at 1-week intervals with indicated antigens (SrtA, 10 μg ...
<p>Mice were grouped (n = 10/group) and immunized three times with SrtA/SCPA or infected with GAS M1...
Background. Group A streptococcus (GAS) infections and poststreptococcal sequelae remain a health pr...
<p>Mice were pretreated with saline (control) or 4 mg/kg peptide (IP) in saline, and infected 4 hour...
<p>A) Kaplan–Meier survival curves. The lethality was monitored for 20 days. The numbers in parenthe...
<p>(A) The average titers of rFSBM-specific serum IgG collected from BALB/c mice that were immunized...
<p>BALB/c mice immunized with 3 doses of rPspAs, rPds, co-administered or hybrid proteins were chall...
<p>BALB/c mice were immunized with the hTM4SF5R2-3 peptide and Lipoplex(O) complex or indicated comb...
Flow chart depicts the schedule and dose of challenge with live P. aeruginosa and treatment with SPA...
<p><b>A.</b> For therapeutic vaccination, mice (n = 5 per group) were inoculated with ID8-G7 tumor c...
<p>MUC1.Tg mice were given two peptide immunizations before and two after tumor challenges. Three ou...
<p>(A) The survival rates of synthetic peptide SLSpp, PP6, or a combination of two peptides (SLSpp/P...
<p>To assess the longevity of immunity developed following sequential infections, BALB/c mice (n = 2...
<p>BALB/c mice (n = 20/group; female, 4–6 weeks old) were sequentially infected multiple times with ...
<p>Bacterial burden in tissues was significantly lower in animal immunized with Peptide B especially...
<p>(A) Mice were i.n immunized three times at 1-week intervals with indicated antigens (SrtA, 10 μg ...
<p>Mice were grouped (n = 10/group) and immunized three times with SrtA/SCPA or infected with GAS M1...
Background. Group A streptococcus (GAS) infections and poststreptococcal sequelae remain a health pr...
<p>Mice were pretreated with saline (control) or 4 mg/kg peptide (IP) in saline, and infected 4 hour...
<p>A) Kaplan–Meier survival curves. The lethality was monitored for 20 days. The numbers in parenthe...
<p>(A) The average titers of rFSBM-specific serum IgG collected from BALB/c mice that were immunized...
<p>BALB/c mice immunized with 3 doses of rPspAs, rPds, co-administered or hybrid proteins were chall...
<p>BALB/c mice were immunized with the hTM4SF5R2-3 peptide and Lipoplex(O) complex or indicated comb...
Flow chart depicts the schedule and dose of challenge with live P. aeruginosa and treatment with SPA...
<p><b>A.</b> For therapeutic vaccination, mice (n = 5 per group) were inoculated with ID8-G7 tumor c...
<p>MUC1.Tg mice were given two peptide immunizations before and two after tumor challenges. Three ou...